Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review

References

• Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc. 2009;6(3):256–259. doi:10.1513/pats.200808-087RM
   PubMedGoogle Scholar
• Kelly FJ, Fussell JC. Air pollution and airway disease. Clin Exp Allergy. 2011;41(8):1059–1071. doi:10.1111/j.1365-2222.2011.03776.x
   PubMed Web of Science ®Google Scholar
• Kelada SN, Aylor DL, Peck BC, et al. Genetic analysis of hematological parameters in incipient lines of the collaborative cross. Genes Genomes Genet. 2012;2(2):157–165. doi:10.1534/g3.111.001776
   Web of Science ®Google Scholar
• Wiwanitkit V. Plateletcrit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters. Clin Appl Thromb Hemost. 2004;10(2):175–178. doi:10.1177/107602960401000208
   PubMed Web of Science ®Google Scholar
• Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50(1):40–47. doi:10.1016/j.jacc.2007.02.067
   PubMed Web of Science ®Google Scholar
• Evans DM, Frazer IH, Martin NG. Genetic and environmental causes of variation in basal levels of blood cells. Twin Res Hum Genet. 1999;2(4):250–257. doi:10.1375/twin.2.4.250
   Google Scholar
• Karabulut A, Uzunlar B. Correlation between red cell distribution width and coronary ectasia in the acute myocardial infarction. Clin Appl Thromb Hemost. 2012;18(5):551–552. doi:10.1177/1076029611436198
   PubMed Web of Science ®Google Scholar
• Montagnana M, Cervellin G, Meschi T, Lippi G. The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med. 2012;50(4):635–641. doi:10.1515/cclm.2011.831
   Web of Science ®Google Scholar
• Bessman JD, Gilmer PR, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol. 1983;80(3):322–326. doi:10.1093/ajcp/80.3.322
   PubMed Web of Science ®Google Scholar
• Adamsson Eryd S, Borné Y, Melander O, et al. Red blood cell distribution width is associated with incidence of atrial fibrillation. J Intern Med. 2014;275(1):84–92. doi:10.1111/joim.12143
   PubMed Web of Science ®Google Scholar
• Koma Y, Onishi A, Matsuoka H, et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS One. 2013;8(11):e80240. doi:10.1371/journal.pone.0080240
   PubMed Web of Science ®Google Scholar
• Song CS, Park DI, Yoon MY, et al. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci. 2012;57(4):1033–1038. doi:10.1007/s10620-011-1978-2
   PubMed Web of Science ®Google Scholar
• Rampling M. Haemorheological disturbances in hypertension: the influence of diabetes and smoking. Clin Hemorheol Microcirc. 1999;21(3–4):183–187.
   PubMed Web of Science ®Google Scholar
• Enawgaw B, Adane N, Terefe B, Asrie F, Melku M. A comparative cross-sectional study of some hematological parameters of hypertensive and normotensive individuals at the university of Gondar hospital, Northwest Ethiopia. BMC Hematol. 2017;17(1):1–7. doi:10.1186/s12878-017-0093-9
   PubMedGoogle Scholar
• Seyoum M, Enawgaw B, Melku M. Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens. Thromb J. 2018;16(1):1–6. doi:10.1186/s12959-018-0170-8
   PubMed Web of Science ®Google Scholar
• Boos CJ, Lip GY. Assessment of mean platelet volume in coronary artery disease—what does it mean? Thromb Res. 2007;120(1):11–13. doi:10.1016/j.thromres.2006.09.002
   PubMed Web of Science ®Google Scholar
• Sahan E, Polat S. Neutrophil to lymphocyte ratio is associated with more extensive, severe and complex coronary artery disease and impaired myocardial perfusion. Turk Kardiyol Dern Ars. 2014;42(4):415. doi:10.5543/tkda.2014.87036
   PubMedGoogle Scholar
• Maton A. Human Biology and Health. Prentice Hall; 1997.
   Google Scholar
• Haas T, Fries D, Tanaka K, Asmis L, Curry N, Schöchl H. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth. 2015;114(2):217–224. doi:10.1093/bja/aeu303
   PubMed Web of Science ®Google Scholar
• Greaves M, Preston FE. Approach to the bleeding patient. In: Colman H, Marder C, editors. Haemostasis and Thrombosis: Basic Principles and Clinical Practice. George Lippincott Williams and Wilkins; 2001.
   Google Scholar
• Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113(13):2878–2887.
   PubMed Web of Science ®Google Scholar
• David SL, George MS. Estrogen and progestins. In: Laurence LB, editor. Goodman & Gillman’s the Pharmacological Basis for Therapeutics. 11th ed. The McGraw Hill companies New York; 2006:1431–1436.
   Google Scholar
• Clinical and Laboratory Standards Institute (NCCLS). Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard, NCCLS Document H3-A5 (ISBN 1-56238-515-1). Fifth ed. 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA: NCCLS; 2003.
   Google Scholar
• Egbunah M, Eze E, Ebirien-Agana B, Jeremiah Z. Haematological profiles of women on some contraceptives in selected family planning clinics in Kaduna State, Nigeria. J Med Sci Clin Res. 2018;6(12):73–84.
   Google Scholar
• Nakada D, Oguro H, Levi BP, et al. Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature. 2014;505(7484):555–558. doi:10.1038/nature12932
   PubMed Web of Science ®Google Scholar
• Milman N, Kirchhoff M, Jørgensen T. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Ann Hematol. 1992;65(2):96–102. doi:10.1007/BF01698138
   PubMed Web of Science ®Google Scholar
• Milman N, Rosdahl N, Lyhne N, Jørgensen T, Graudal N. Iron status in Danish women aged 35–65 years: relation to menstruation and method of contraception. Acta Obstet Gynecol Scand. 1993;72(8):601–605. doi:10.3109/00016349309021150
   PubMed Web of Science ®Google Scholar
• Prasad AS, Oberleas D, Moghissi K, Lei K, Stryker JC. Effect of oral contraceptive agents on nutrients: i. Minerals. Am J Clin Nutr. 1975;28(4):377–384. doi:10.1093/ajcn/28.4.377
   PubMed Web of Science ®Google Scholar
• Burton J. Effect of oral contraceptives on haemoglobin, packed-cell volume, serum-iron, and total iron-binding capacity in healthy women. Lancet. 1967;289(7497):978–980. doi:10.1016/S0140-6736(67)92359-8
   Google Scholar
• Milman N, Clausen J, Byg K-E. Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol. 1998;77(1):13–19. doi:10.1007/s002770050405
   PubMed Web of Science ®Google Scholar
• Beard JL. Iron requirements in adolescent females. J Nutr. 2000;130(2):440S–442S. doi:10.1093/jn/130.2.440S
   PubMed Web of Science ®Google Scholar
• Briggs M, Briggs M. Contraceptives and serum proteins. Br Med J. 1970;3(5721):521. doi:10.1136/bmj.3.5721.521-a
   PubMed Web of Science ®Google Scholar
• Grant EC. Hormone balance of oral contraceptives. BJOG. 1967;74(6):908–918. doi:10.1111/j.1471-0528.1967.tb15578.x
   Google Scholar
• Margen S, King JC. Effect of oral contraceptive agents on the metabolism of some trace minerals. Am J Clin Nutr. 1975;28(4):392–402. doi:10.1093/ajcn/28.4.392
   PubMed Web of Science ®Google Scholar
• Massé PG, Andrée G. Long-term effect of low-dose combined steroid contraceptives on body iron status. Contraception. 1992;46(3):243–252. doi:10.1016/0010-7824(92)90005-E
   PubMed Web of Science ®Google Scholar
• Frassinelli-Gunderson EP, Margen S, Brown JR. Iron stores in users of oral contraceptive agents. Am J Clin Nutr. 1985;41(4):703–712. doi:10.1093/ajcn/41.4.703
   PubMed Web of Science ®Google Scholar
• Yeasmin T, Haque MS, Yeasmin S, Amin MR. Iron status in women using oral contraceptives. Bangladesh J Physiol Pharmacol. 2010;26(1–2):25–29. doi:10.3329/bjpp.v26i1-2.19963
   Google Scholar
• Davis A, Godwin A, Lippman J, Olson W, Kafrissen M. Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding. Obstet Gynecol. 2000;96(6):913–920.
   PubMed Web of Science ®Google Scholar
• Sim M, Dawson B, Landers G, Trinder D, Peeling P. Iron regulation in athletes: exploring the menstrual cycle and effects of different exercise modalities on hepcidin production. Int J Sport Nutr Exerc Metab. 2014;24(2):177–187. doi:10.1123/ijsnem.2013-0067
   PubMed Web of Science ®Google Scholar
• Prema K. Haemoglobin levels in contraceptive users. Indian J Med Res. 1979;69:756–760.
   PubMed Web of Science ®Google Scholar
• McArthur JO, Tang H, Petocz P, Samman S. Biological variability and impact of oral contraceptives on vitamins B6, B12 and folate status in women of reproductive age. Nutrients. 2013;5(9):3634–3645. doi:10.3390/nu5093634
   PubMed Web of Science ®Google Scholar
• Wakeman MP. A review of the effects of oral contraceptives on nutrient status, with especial consideration to folate in UK. J Adv Med Med Res. 2019;1–17. doi:10.9734/jammr/2019/v30i230168
   Google Scholar
• Shere M, Bapat P, Nickel C, Kapur B, Koren G. Association between use of oral contraceptives and folate status: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2015;37(5):430–438. doi:10.1016/S1701-2163(15)30258-9
   PubMedGoogle Scholar
• Berenson AB, Rahman M. Effect of hormonal contraceptives on vitamin B12 level and the association of the latter with bone mineral density. Contraception. 2012;86(5):481–487. doi:10.1016/j.contraception.2012.02.015
   PubMed Web of Science ®Google Scholar
• Kuhl H, März W, Jung-Hoffmann C, Heidt F, Gross W. Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives. Am J Obstet Gynecol. 1990;163(1):363–369. doi:10.1016/0002-9378(90)90583-S
   PubMed Web of Science ®Google Scholar
• Zia A, Callaghan MU, Callaghan JH, et al. Hypercoagulability in adolescent girls on oral contraceptives‐global coagulation profile and estrogen receptor polymorphisms. Am J Hematol. 2015;90(8):725–731. doi:10.1002/ajh.24064
   PubMed Web of Science ®Google Scholar
• McGregor L, Toor B, McGregor J, Renaud S, Clemetson K. Effects of oral contraceptives, or lanosterol, on ADP-induced aggregation and binding of 125I-fibrinogen to rat platelets. Thromb Res. 1984;33(5):517–522. doi:10.1016/0049-3848(84)90017-3
   PubMed Web of Science ®Google Scholar
• Ciavatti M, Davenas E, Blache D, Monnier MA, Renaud S. Biosynthesis of platelet lipids in relation to aggregation in women using oral contraceptives. Contraception. 1982;25(6):629–638. doi:10.1016/0010-7824(82)90064-6
   PubMed Web of Science ®Google Scholar
• O’Donnell CJ, Larson MG, Feng D, et al. Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation. 2001;103(25):3051–3056. doi:10.1161/01.CIR.103.25.3051
   PubMed Web of Science ®Google Scholar
• Harrison R, McKee P. Estrogen stimulates von Willebrand factor production by cultured. Blood. 1984;63(3):657–665. doi:10.1182/blood.V63.3.657.657
   PubMed Web of Science ®Google Scholar
• Kenneth AB, Gregory YH. Overview of the causes of VTE- oral and transdermal contraceptives. Available from: http://www.update.com/content/overviewofvenousthrombosis. Accessed August 20, 2022.
   Google Scholar
• Poort S, Rosendaal F, Reitsma P, Bertina R. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88(10):3698–3703. doi:10.1182/blood.V88.10.3698.bloodjournal88103698
   PubMed Web of Science ®Google Scholar
• Kraaijenhagen RA, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Büller HR. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 2000;83(01):5–9. doi:10.1055/s-0037-1613747
   PubMedGoogle Scholar
• Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994;269(29):18735–18738. doi:10.1016/S0021-9258(17)32228-7
   PubMed Web of Science ®Google Scholar
• Winkler UH. Blood coagulation and oral contraceptives: a critical review. Contraception. 1998;57(3):203–209. doi:10.1016/S0010-7824(98)00020-1
   PubMed Web of Science ®Google Scholar
• Meijers JC, Middeldorp S, Tekelenburg W, et al. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis. Thromb Haemost. 2000;84(07):9–14. doi:10.1055/s-0037-1613959
   PubMedGoogle Scholar
• Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem. 1995;270(24):14477–14484. doi:10.1074/jbc.270.24.14477
   PubMed Web of Science ®Google Scholar
• van Tilburg NH, Rosendaal FR, Bertina RM. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood. 2000;95(9):2855–2859.
   PubMed Web of Science ®Google Scholar
• Evans K, Amenhotep Z, Dawson D, Waters H, Ardern J. Chapter 9.11 - Hematology. In: Wild D, editor. The Immunoassay Handbook. Fourth ed. Oxford: Elsevier; 2013:795–815.
   Google Scholar
• Coffie S, Abaka-Yawson A, Quarshie SS, et al. Effects of hormonal contraceptives on haematological parameters among women in the cape coast metropolis, Ghana. Asian Hematol Res J. 2020;3(1):1–9.
   Google Scholar
• Bathija H, Lei Z, Cheng X, et al. Effects of contraceptives on hemoglobin and ferritin. Contraception. 1998;58(5):261–273.
   Web of Science ®Google Scholar
• Buchan PC, MacDonald HN. Altered haemorheology in oral-contraceptive users. Br Med J. 1980;280(6219):978–979. doi:10.1136/bmj.280.6219.978
   PubMed Web of Science ®Google Scholar
• Afsar NA, Barakzai Q, Adil SN. Effect of A ‘Progestin Only’Contraceptive on platelet aggregation in a Pakistani set of population. J Ayub Med Coll Abbottabad. 2005;17(3):1–6.
   Google Scholar
• Akinloye O, Adebayo T, Oguntibeju OO, Oparinde D, Ogunyemi E. Effects of contraceptives on serum trace elements, calcium and phosphorus levels. West Indian Med J. 2011;60(3):308–315.
   PubMed Web of Science ®Google Scholar
• Abubakar SB. Some haemostatic changes in women on hormonal contraceptives attending family planning clinic at Ahmadu Bello University Teaching Hospital Shika-Zaria, Nigeria. Faculty of Internal Medicine; 2013.
   Google Scholar
• Bulur S, Albayrak M, Keskin F, et al. Effect of combined oral contraceptive use on platelet volume in women at reproductive age. Clin Exp Obstet Gynecol. 2012;39(3):314–316.
   PubMed Web of Science ®Google Scholar
• Babatunde A, Olatunji P. Short-term effect of oral contraceptive pills on some haemostatic parameters in healthy Nigerian women. Niger Postgrad Med J. 2004;11(4):246–250.
   PubMedGoogle Scholar
• Joseph J, Abdulazeez A, Obisesan O. Effect of hormonal contraceptives on some haemostatics parameters in women attending family planning clinics in Jos, Nigeria. Niger J Health Biomed Sci. 2008;7(1):15–18. doi:10.4314/njhbs.v7i1.11656
   Google Scholar
• Afsar NA, Barakzai Q, Adil SN. Effect of low dose oral pill on haemostatic parameters in a set of Pakistani population. J Pak Med Assoc. 2008;58(5):229.
   PubMedGoogle Scholar
• Stegnar M. Thrombophilia screening--at the right time, for the right patient, with a good reason. Clin Chem Lab Med. 2010;48:S105–S13. doi:10.1515/CCLM.2010.367
   PubMed Web of Science ®Google Scholar
• Jennings I, Cooper P. Screening for thrombophilia: a laboratory perspective. Br J Biomed Sci. 2003;60(1):39–51. doi:10.1080/09674845.2003.11783675
   PubMed Web of Science ®Google Scholar
• Inman W, Vessey M, Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J. 1970;2(5703):203–209. doi:10.1136/bmj.2.5703.203
   PubMed Web of Science ®Google Scholar
• Leck I, Thomson J, Bocaz J, et al. A multicentre study of coagulation and haemostatic variables during oral contraception: variations with geographical location and ethnicity. Int J Epidemiol. 1991;20(4):913–920. doi:10.1093/ije/20.4.913
   PubMed Web of Science ®Google Scholar
• Famodu A. Serial changes in plasma fibrinogen concentration and fibrinolytic activity in African women on oral contraceptive pills. Afr J Reprod Health. 1997;1(2):90–95. doi:10.2307/3583380
   PubMedGoogle Scholar
• Sirhindi GA, Tayyib M, Tasneem T, Farooq M, Chaudhary NA. Fibrinogen degradation products and coagulation parameters in women taking oral contraceptives. Ann King Edw Med Univ. 2003;9(3). doi:10.21649/akemu.v9i3.1331
   Google Scholar
• Chan P, Yeh CJ, Pan WH. Influence of contraceptive pill use, premenopause and postmenopausal state on hemostatic parameters in ethnic Chinese women. J Thromb Thrombolysis. 1996;3(1):9–12. doi:10.1007/BF00226404
   PubMedGoogle Scholar
• Elsayid M, Elbasheer MAM, Elgari MM, Elfaki T. The effect of contraceptive pills on coagulation tests among Sudanese women in Khartoum State-Sudan; 2016.
   Google Scholar
• Rodak BF, Keohane EM, Fritsma GA. Hematology-E-Book: Clinical Principles and Applications. Elsevier Health Sciences; 2013.
   Google Scholar
• Mohammed E, Ahmed E, Eldirderi S, Gafar S. Research article effect of oral contraceptives on coagulation parameters among Sudanese women in Khartoum state. EC Gynaecol. 2020;9:1–5.
   Google Scholar
• Middeldorp S, Meijers JC, van den Ende AE, et al. Effects on coagulation of levonorgestrel-and desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost. 2000;84(07):4–8. doi:10.1055/s-0037-1613958
   PubMedGoogle Scholar
• van Hylckama Vlieg A, Helmerhorst F, Vandenbroucke J, Doggen C, Rosendaal F. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009;339:b2921.
   PubMed Web of Science ®Google Scholar
• Bhagavan NV, Ha C-E. Chapter 34 - biochemistry of hemostasis. In: Bhagavan NV, Ha C-E, editors. Essentials of Medical Biochemistry. Second ed. San Diego: Academic Press; 2011:637–660.
   Google Scholar
• Osman ZAA, Babiker SE, Babiker NE. Estimation of D-dimer level among Sudanese women under contraceptive pill. J Drug Deliv Ther. 2019;9(6–s):53–57. doi:10.22270/jddt.v9i6-s.3738
   Google Scholar
• Sehovic N, Smith KP. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products. Ann Pharmacother. 2010;44(5):898–903. doi:10.1345/aph.1M649
   PubMed Web of Science ®Google Scholar
• Plu-Bureau G, Maitrot-Mantelet L, Hugon-Rodin J, Canonico M. Hormonal contraceptives and venous thromboembolism: an epidemiological update. Best Pract Res Clin Endocrinol Metab. 2013;27(1):25–34. doi:10.1016/j.beem.2012.11.002
   PubMed Web of Science ®Google Scholar
• Zöller B, Li X, Ohlsson H, Ji J, Sundquist J, Sundquist K. Family history of venous thromboembolism as a risk factor and genetic research tool. Thromb Haemost. 2015;114(11):890–900. doi:10.1160/TH15-04-0306
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890–b2890. doi:10.1136/bmj.b2890
   PubMed Web of Science ®Google Scholar